COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization

COVID-19 in Patients with Rheumatic Disease Using Immunomodulatory Drugs: Imaging Findings and Predictors of Hospitalization

Abstract Introduction SARS-CoV-2 causes more severe symptoms in most chronic diseases, and rheumatic disease is no exception. This study aims to investigate whether there is an association between the use of immunomodulatory medications, including conventional disease-modifying agents (csDMARDs), gl...

Full description

Bibliographic Details
Main Authors: Hossein Azizi, Hanie Karimi, Mahdi Kazemi, Somaye Sadat Rezaei, Amirhossein Parsaei, Mohammad Aghaali, Jamshid Vafaeimanesh, Pouya Torabi, Behnam Amini, Maryam Masoumi
Format: Article
Language:English
Published: Adis, Springer Healthcare 2022-12-01
Series:Rheumatology and Therapy
Subjects:
Rheumatoid arthritis
COVID-19
Immunomodulatory drugs
DMARDs
CT-scan severity score
Online Access:https://doi.org/10.1007/s40744-022-00508-y

Internet

https://doi.org/10.1007/s40744-022-00508-y

Similar Items